BCRX vs KIM · rev $374.7M vs P/E 27, rev $1.11B
BioCryst Pharmaceuticals Inc (BCRX) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported KIM revenue for 2026-06-30 was $1.11B. Net income was $318.2M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
BCRX currently screens at market cap $1.83B. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the BCRX and KIM stock pages for the full models.
Not investment advice.